SEC Form 4 · accession 0001225208-16-028427
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel J. Brennan
Officer — EVP and CFO
Period of report
Feb 24, 2016
Accepted (ET)
Feb 26, 2016 · 4:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 24, 2016 | M | 40,214 | $8.30 | A | 202,659 | D | |
| Common Stock | Feb 24, 2016 | M | 20,461 | $7.41 | A | 223,120 | D | |
| Common Stock | Feb 24, 2016 | M | 12,422 | $7.16 | A | 235,542 | D | |
| Common Stock | Feb 24, 2016 | M | 7,572 | $7.39 | A | 243,114 | D | |
| Common Stock | Feb 24, 2016 | M | 6,093 | $6.28 | A | 249,207 | D | |
| Common StockF2 | Feb 24, 2016 | M | 5,734 | $0.00 | A | 254,941 | D | |
| Common Stock | Feb 24, 2016 | F | 2,701 | $17.33 | D | 252,240 | D | |
| Common StockF3 | Feb 24, 2016 | S | 99,591 | $17.21 | D | 152,649 | D | |
| Common Stock | Feb 25, 2016 | S | 3,620 | $17.48 | D | 149,029 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF2,F4 | — | Feb 24, 2016 | M | 5,734 | D | — | Feb 24, 2019 | Common Stock | 5,734 | 17,202 | D |
| Stock Option (Right to Buy)F5 | $7.41 | Feb 24, 2016 | M | 20,461 | D | — | Feb 16, 2020 | Common Stock | 20,461 | 81,847 | D |
| Stock Option (Right to Buy)F6 | $8.30 | Feb 24, 2016 | M | 40,214 | D | — | Feb 24, 2019 | Common Stock | 40,214 | 0 | D |
| Stock Option (Right to Buy)F7 | $6.28 | Feb 24, 2016 | M | 6,093 | D | — | Feb 27, 2022 | Common Stock | 6,093 | 24,373 | D |
| Stock Option (Right to Buy)F8 | $7.16 | Feb 24, 2016 | M | 12,422 | D | — | Feb 28, 2021 | Common Stock | 12,422 | 49,690 | D |
| Stock Option (Right to Buy)F9 | $7.39 | Feb 24, 2016 | M | 7,572 | D | — | Feb 28, 2023 | Common Stock | 7,572 | 30,288 | D |
Explanation of responses
- F1This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F3Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.11 to $17.32, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
- F5Grant to the reporting person of an option to purchase 102,308 shares of common stock on February 16, 2010. This option is fully vested.
- F6Grant to the reporting person of an option to purchase 40,214 shares of common stock on February 24, 2009. This option is fully vested.
- F7Grant to the reporting person of an option to purchase 30,466 shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
- F8Grant to the reporting person of an option to purchase 62,112 shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.
- F9Grant to the reporting person of an option to purchase 37,860 shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.